GNPNAT1 and prostate carcinoma: Compared to benign tissue, prostate cancers contained elevated levels of GNPNAT1 and UAP1 transcripts, which was consistent with increased activity of HBP in matched tumor–benign pairs as detected when levels of UDP-GlcNAc were measured [27].